Cortexyme Announces Further Layoffs, Chief Medical Officer Leaves

Benzinga2022-05-03

Cortexyme Inc (NASDAQ: CRTX) has announced additional headcount reductions as part of its previously announced cost reduction program. The restructuring is to rationalize operations and allow ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2232126069?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FTfJHpM905sIoygR3TUQkw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/SNCjA6SExqPGVXAKIZB2rg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/0732db4226fc5272785b2e9e474a4d31","is_english":true,"pubTime":"2022-05-03 21:56","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2232126069","market":"us","top_or_hot":-1,"title":"Cortexyme Announces Further Layoffs, Chief Medical Officer Leaves","media":"Benzinga","content":"<div>\n<p>Cortexyme Inc (NASDAQ: CRTX) has announced additional headcount reductions as part of its previously announced cost reduction program.\nThe restructuring is to rationalize operations and allow ...</p>\n\n<a href=\"https://finance.yahoo.com/news/cortexyme-announces-further-layoffs-chief-135639997.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cortexyme Announces Further Layoffs, Chief Medical Officer Leaves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCortexyme Announces Further Layoffs, Chief Medical Officer Leaves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-03 21:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cortexyme-announces-further-layoffs-chief-135639997.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cortexyme Inc (NASDAQ: CRTX) has announced additional headcount reductions as part of its previously announced cost reduction program.\nThe restructuring is to rationalize operations and allow ...</p>\n\n<a href=\"https://finance.yahoo.com/news/cortexyme-announces-further-layoffs-chief-135639997.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://finance.yahoo.com/news/cortexyme-announces-further-layoffs-chief-135639997.html","article_id":"2232126069","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FTfJHpM905sIoygR3TUQkw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/SNCjA6SExqPGVXAKIZB2rg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/0732db4226fc5272785b2e9e474a4d31"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2232126069","pubTimestamp":1651586199,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Cortexyme Inc (NASDAQ: CRTX) has announced additional headcount reductions as part of its previously","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技"},"translate_title":"Cortexyme宣布进一步裁员，首席医疗官离职","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRTX":0.9},"content_text":"Cortexyme Inc (NASDAQ: CRTX) has announced additional headcount reductions as part of its previously announced cost reduction program.\nThe restructuring is to rationalize operations and allow continued support for its business needs following the clinical hold on atuzaginstat’s (COR388) Investigational New Drug application. \nThe company is further reducing its headcount by 36%, bringing the total reduction to 67% from the January 2022 headcount levels.\nThe majority of this current reduction in force is expected to occur by the end of May 2022, and the remainder is expected to be completed by the end of July 2022.\nIn connection with this current reduction in force, the company estimates to incur approximately $0.7 million in expenses.\nAlso Read: Cortexyme Posts Safety Data From SAD Portion Of COR588 Trial In P.Gingivalis.\nAdditionally, Michael Detke, the company’s Chief Medical Officer, will step down effective May 2.\nPrice Action: Monday, CRTX shares traded 0.72% lower at $47.99.\n\nSee more from Benzinga\n\nThe Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs\n\nDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.\n© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2232126069"}